Trial Profile
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2019
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Hallux
- 14 Jan 2019 Status changed from active, no longer recruiting to completed.
- 13 May 2018 Planned End Date changed from 1 Jul 2018 to 1 Oct 2018.
- 13 May 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Oct 2018.